YMC Co., Ltd. (“YMC”), a leading supplier of separation resins, services and systems for the pharmaceutical market, has acquired all shares in ChromaCon AG (Zurich, Switzerland) and executed the transfer of 100% shares in the Company on April 1st, 2019.
ChromaCon AG, founded as spin-off from ETH Zurich and a life science tool company, is a leader in continuous chromatography technologies. ChromaCon markets laboratory-scale purification systems employing its process technologies, process simulation and operating software. ChromaCon has pioneered twin-column purification, significantly increasing productivity in large (biopharmaceutical) and small (pharmaceutical) molecule manufacturing, thereby reducing operational cost.
YMC and ChromaCon have been cooperating in Japan and India for the marketing & sale of ChromaCon’s lab-scale systems. In addition, ChromaCon has licensed proprietary technologies to YMC Process Technologies (“YPT”) for GMP production scale equipment. YMC completed its acquisition of YPT from LEWA-Nikkiso America in December 2018. YPT develops and manufactures pilot- and production-scale separation systems for the (bio-)pharmaceutical manufacturing industry.